Cervical cancer screening is a crucial step in the early detection of cervical cancer, one of the leading causes of cancer-related deaths among women worldwide. One increasingly popular method for this screening is Liquid-Based Cytology (LBC). LBC offers several advantages over conventional methods, such as the Pap smear, by providing more representative and accurate results.

Human papillomavirus (HPV) is the leading cause of cervical cancer, a disease that remains one of the top causes of death among women worldwide. Conventional methods like Pap smears have been the standard for screening, but limitations in accessibility and comfort often reduce participation. Urine-based HPV DNA testing is now emerging as an innovative alternative, offering a non-invasive, comfortable, accurate approach that can be applied to a broader population.

Human Papillomavirus (HPV) is a common virus that can infect the skin and mucous membranes of the body, such as the mouth, throat, cervix, and genital areas. While many people are aware of HPV risks in women, especially related to cervical cancer, there is still a lack of awareness about its impact on men. HPV can also lead to various cancers in men, including penile, anal, and oropharyngeal (mouth and throat) cancers.

“Our study, for the first time, demonstrates that analyzing mucus samples can distinguish cervical tumors from normal tissues more accurately than serum samples,” said Professor Takuma Fujii from Fujita Health University who led the research team. “Using such a method as an additional option to traditional screening techniques could help discover cancer and precancerous conditions at an earlier stage"...

Human Papillomavirus (HPV) is a virus that spreads through sexual contact and is a leading cause of cervical cancer. HPV DNA testing is an essential tool for the early detection of HPV infection and assessing the risk of cervical cancer. This article provides an in-depth explanation of HPV DNA testing, including its basic principles, procedures, benefits, and implications.

Every year, World Health Day is commemorated as a significant moment to highlight the global challenges faced in efforts to create healthier communities. With the theme "Healthy Communities, Healthy World," World Health Day emphasizes the importance of cross-sector collaboration to achieve inclusive and sustainable health transformation.

Cervical cancer is one of the most common types of cancer affecting women worldwide. However, many women still lack information about this disease, which can lead to late diagnosis and ineffective treatment. Therefore, it is crucial for every woman to empower herself with accurate information about cervical cancer and the steps that can be taken to prevent and manage this disease.

Cancer remains a significant challenge in the field of healthcare, but there is strong hope that early detection can change the game. Early cancer detection has brought significant successes in prognosis and recovery, yet there are challenges to overcome to achieve better detection rates in the future.

Cervical cancer is one of the most common types of cancer occurring in women worldwide. This cancer is typically caused by infection with the Human Papilloma Virus (HPV). HPV is a family of DNA viruses with over 200 types that can infect humans. Some types of HPV, particularly high-risk types, can lead to cell changes that have the potential to become cancerous. In this article, we will discuss the specific types of HPV that are associated with two types of cervical cancer: adenocarcinoma and adenosquamous carcinoma.